Lycopodium C Liquid
NDC Package 15631-2829-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Lycopodium C liquids is condition listed above or as directed by the physician. This formulation utilizes a liquid delivery system. Marketed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, this product is identified by NDC 15631-2829.

Identification & Billing

NDC Package Code
15631-2829-0
Package Description
10 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
15631282900

Clinical Specifications

Proprietary Name
Lycopodium C
Non-Proprietary Name
Lycopodium C
Substance Name
Lycopodium Clavatum Spore
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Condition listed above or as directed by the physician

Regulatory & Marketing

Labeler Name
Rxhomeo Private Limited D.b.a. Rxhomeo, Inc
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
05-23-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (15631-2829). Click a package code to view its specific billing and regulatory data.

30 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 15631-2829-0 identifies a specific commercial package of 10 ml in 1 bottle of Lycopodium C, a human over the counter drug labeled by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. This liquid is formulated for oral use and contains lycopodium clavatum spore as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc on May 23, 2024. The current certification is valid through December 31, 2026.

How is this Rxhomeo Private Limited D.b.a. Rxhomeo, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 15631282900. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
15631-2829-0
11-Digit CMS (5-4-2)
15631-2829-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.